Yoshitaka Nabeshima
- Epidemiology top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Hepatology top 5%
- Pathology and Forensic Medicine top 10%
- Clinical Biochemistry top 5%
- Co-authors
- Kazuaki ChayamaHideyuki HyogoTomokazu IshitobiKoji ArihiroSusumu TazumaMotoki InoueKeiko IwamotoMichihiro Nonaka
- Topics
- Liver Disease Diagnosis and Treatment (8 papers)Diet, Metabolism, and Disease (5 papers)Hepatitis C virus research (4 papers)
In The Last Decade
Yoshitaka Nabeshima
10 papers receiving 639 citations
Peers
Comparison fields: 5 of 55
- Epidemiology 474
- Endocrinology, Diabetes and Metabolism 319
- Hepatology 168
- Pathology and Forensic Medicine 141
- Clinical Biochemistry 137
Countries citing papers authored by Yoshitaka Nabeshima
This map shows the geographic impact of Yoshitaka Nabeshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Nabeshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Nabeshima more than expected).
Fields of papers citing papers by Yoshitaka Nabeshima
This network shows the impact of papers produced by Yoshitaka Nabeshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Nabeshima. The network helps show where Yoshitaka Nabeshima may publish in the future.
Co-authorship network of co-authors of Yoshitaka Nabeshima
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Nabeshima. A scholar is included among the top collaborators of Yoshitaka Nabeshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Nabeshima. Yoshitaka Nabeshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 138 | |
| 3 | 35 | |
| 4 | 54 | |
| 5 | 177 | |
| 6 | 159 | |
| 7 | 71 | |
| 8 | 2 | |
| 9 | 16 | |
| 10 | Lack of effective messenger RNA for beta 2-microglobulin in a gestational human choriocarcinoma cell line (GCH-1). | 9 |
About Yoshitaka Nabeshima
Yoshitaka Nabeshima is a scholar working on Hepatology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 10 papers that have together received 662 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (5 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Hepatology (168 citations), Clinical Biochemistry (137 citations) and Endocrinology, Diabetes and Metabolism (319 citations). Yoshitaka Nabeshima has collaborated with scholars based in Japan and Russia. Frequent co-authors include Kazuaki Chayama, Hideyuki Hyogo, Tomokazu Ishitobi, Koji Arihiro, Susumu Tazuma, Motoki Inoue, Keiko Iwamoto, Michihiro Nonaka, Masayoshi Takeuchi and Yuki Kimura. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Hepatology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.